The article you requested is
Benztropine in the Treatment of Venlafaxine-Induced Sweating
J Clin Psychiatry 1997;58:176-177 [letter]
Copyright 1997 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $40
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP print + online for $166 individual.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Letter to the Editor
Sir: Sweating is a relatively common side effect seen with
serotonin selective reuptake inhibitors (SSRIs) and has been reported
in 7% to 11% of patients treated with SSRIs and 12% of
patients treated with venlafaxine, an antidepressant with the
ability to inhibit the reuptake of serotonin and norepinephrine.
The following case indicates that this side effect can cause severe
social disruption and limit effective treatment of depression.
A possible management strategy is also suggested.